Mar 25, 2022 (TheNewswire.ca via COMTEX) -- (via TheNewswire)
Vancouver, British Columbia - TheNewswire - March 25, 2022.Lexston Life Sciences Corp. /zigman2/quotes/227714303/delayed CA:LEXT +10.00% (the "Company" or "Lexston") announces the resignation of Dimitrios Mitrakos as the Chief Financial Officer and Corporate Secretary of the Company and the appointment of Company's director Jatinder Jesse Manhas as the Chief Financial Officer and Corporate Secretary of the Company.
The Company also announces the appointment of director Graeme Staley to the audit committee of the Company. The audit committee of the Company now consists of directors Jagdip Singh Bal, Harinder Bains and Graeme Staley.
The Company thanks Mr. Mitrakos for his service as the Chief Financial Officer and Corporate Secretary.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2022 TheNewswire - All rights reserved.
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.